Gates Foundation to spend $120 million to speed access to generics of Merck COVID-19 pill
Go back to Gates Foundation to spend $120 million to speed access to generics of Merck COVID-19 pill| Merck & Co. (NYSE: MRK) | Delayed: 119.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.09 | 52 Week High | $65.46 | |||
| Open | $119.09 | 52 Week Low | $47.97 | |||
| Day High | $119.09 | P/E | 81.01 | |||
| Day Low | $119.09 | EPS | $1.47 | |||
| Volume | 7,060 | |||||
